cbl-3: a new mammalian cbl family protein

被引:95
作者
Keane, MM
Ettenberg, SA
Nau, MM
Banerjee, P
Cuello, M
Penninger, J
Lipkowitz, S
机构
[1] Bethesda Naval Hosp, Dept Genet, Med Branch, NCI, Bethesda, MD 20889 USA
[2] Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Amgen Inst, Toronto, ON, Canada
[3] Univ Toronto, Dept Immunol, Ontario Canc Inst, Amgen Inst, Toronto, ON, Canada
关键词
cbl proteins; EGF receptor; signal transduction;
D O I
10.1038/sj.onc.1202753
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have cloned a new human gene, cbl-3, which encodes a protein with marked homology to the cbl family of proteins. The predicted protein encoded by this gene retains the conserved phosphotyrosine binding domain (PTB) in the N-terminal and the zinc finger but is significantly shorter (MW 52.5 kDa) than the other mammalian cbl proteins. The protein lacks the extensive proline rich domain and leucine zipper seen in c-cbl and cbl-b and structurally most resembles the C. elegans and Drosophila cbl proteins. The gene is ubiquitously expressed with highest expression in the aerodigestive tract, prostate, adrenal gland, and salivary gland. The protein is phosphorylated and recruited to the EGFR upon EGF stimulation and inhibits EGF stimulated MAP kinase activation. In comparison to the other mammalian cbl proteins (e.g. cbl-b), cbl-3 interacts with a restricted range of proteins containing Src Homology 3 regions, An alternatively spliced form of the cbl-3 protein was also identified which deletes a critical region of the PTB domain and which does not interact with the EGFR nor inhibit EGF stimulated MAP kinase activation. These data demonstrate that cbl-3, a novel mammalian cbl protein, is a regulator of EGFR mediated signal transduction.
引用
收藏
页码:3365 / 3375
页数:11
相关论文
共 43 条
[1]  
Ausubel FM., 1994, Curr. Protoc. Mol. Biol
[3]  
BLAKE TJ, 1991, ONCOGENE, V6, P653
[4]   Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation [J].
Bustelo, XR ;
Crespo, P ;
LopezBarahona, M ;
Gutkind, JS ;
Barbacid, M .
ONCOGENE, 1997, 15 (21) :2511-2520
[5]   ABERRANT SUBCELLULAR-LOCALIZATION OF BRCA1 IN BREAST-CANCER [J].
CHEN, YM ;
CHEN, CF ;
RILEY, DJ ;
ALLRED, DC ;
CHEN, PL ;
VONHOFF, D ;
OSBORNE, CK ;
LEE, WH .
SCIENCE, 1995, 270 (5237) :789-791
[6]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[7]   MODULAR BINDING DOMAINS IN SIGNAL-TRANSDUCTION PROTEINS [J].
COHEN, GB ;
REN, RB ;
BALTIMORE, D .
CELL, 1995, 80 (02) :237-248
[8]   PROMOTER SEQUENCES OF EUKARYOTIC PROTEIN-CODING GENES [J].
CORDEN, J ;
WASYLYK, B ;
BUCHWALDER, A ;
CORSI, PS ;
KEDINGER, C ;
CHAMBON, P .
SCIENCE, 1980, 209 (4463) :1406-1414
[9]  
Davis LG., 1986, Basic Methods in Molecular Biology
[10]   ERBB-2 IS A POTENT ONCOGENE WHEN OVEREXPRESSED IN NIH/3T3 CELLS [J].
DIFIORE, PP ;
PIERCE, JH ;
KRAUS, MH ;
SEGATTO, O ;
KING, CR ;
AARONSON, SA .
SCIENCE, 1987, 237 (4811) :178-182